ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 040047957. A total of 4 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,720,000 | +347.7% | 72,300 | +186.9% | 0.01% | +150.0% |
| Q3 2021 | $1,501,000 | -51.2% | 25,200 | -44.1% | 0.00% | -50.0% |
| Q2 2021 | $3,076,000 | +154.8% | 45,100 | +159.2% | 0.00% | +100.0% |
| Q1 2021 | $1,207,000 | +149.4% | 17,400 | +176.2% | 0.00% | +100.0% |
| Q4 2020 | $484,000 | -90.7% | 6,300 | -90.9% | 0.00% | -93.8% |
| Q3 2020 | $5,205,000 | +16.5% | 69,600 | -2.0% | 0.02% | -23.8% |
| Q2 2020 | $4,469,000 | +2369.1% | 71,000 | +1551.2% | 0.02% | +2000.0% |
| Q1 2020 | $181,000 | -62.1% | 4,300 | -59.0% | 0.00% | -66.7% |
| Q4 2019 | $477,000 | -20.5% | 10,500 | -19.8% | 0.00% | -40.0% |
| Q3 2019 | $600,000 | -52.6% | 13,100 | -39.4% | 0.01% | -54.5% |
| Q2 2019 | $1,266,000 | +156.8% | 21,600 | +96.4% | 0.01% | +120.0% |
| Q1 2019 | $493,000 | -70.5% | 11,000 | -74.4% | 0.01% | -64.3% |
| Q4 2018 | $1,671,000 | -58.3% | 42,900 | -50.7% | 0.01% | -56.2% |
| Q3 2018 | $4,004,000 | -7.7% | 87,000 | -12.6% | 0.03% | -13.5% |
| Q2 2018 | $4,338,000 | +32.5% | 99,500 | +20.0% | 0.04% | +12.1% |
| Q1 2018 | $3,275,000 | -20.7% | 82,900 | -31.8% | 0.03% | +13.8% |
| Q4 2017 | $4,131,000 | +141.7% | 121,600 | +81.5% | 0.03% | +81.2% |
| Q3 2017 | $1,709,000 | +11.7% | 67,000 | -26.1% | 0.02% | 0.0% |
| Q2 2017 | $1,530,000 | – | 90,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|